Literature DB >> 24166300

MicroRNA maturation and human disease.

Marlen Hesse1, Christoph Arenz.   

Abstract

Numerous studies describe alterations in the levels of specific microRNAs (miRNAs) that are associated with human pathologies. Some of these alterations may give rise to the development of novel diagnostic tools, while certain miRNAs additionally could serve as novel drug targets. Moreover, components of the miRNA maturation machinery may be up- or down-regulated in human disease. In such cases, the consequences for the expression of individual miRNAs are however only poorly understood. Herein, we review the current knowledge of how miRNAs are linked to human disease and which parts of the miRNA maturation machinery could serve as future drug targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24166300     DOI: 10.1007/978-1-62703-703-7_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.

Authors:  Ying Liu; Haiyan Li; Congying Zhao; Hanbing Jia
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

Review 2.  Towards a molecular understanding of microRNA-mediated gene silencing.

Authors:  Stefanie Jonas; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2015-06-16       Impact factor: 53.242

3.  The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Lin Jiang; Chaofu Wang; Canlin Sun; Yumin Xu; Zhongqi Ding; Xueling Zhang; Junxing Huang; Hong Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Identification of microRNA signature and potential pathway targets in prostate cancer.

Authors:  Ahmed A Moustafa; Mohammed Ziada; Abubaker Elshaikh; Amrita Datta; Hogyoung Kim; Krzysztof Moroz; Sudesh Srivastav; Raju Thomas; Jonathan L Silberstein; Krishnarao Moparty; Fatma Elzahraa H Salem; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-08

Review 5.  Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease.

Authors:  Luis Vaca
Journal:  Sensors (Basel)       Date:  2014-05-22       Impact factor: 3.576

6.  Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma.

Authors:  Yongfang Xie; Ling Wang; Zengyan Xie; Chuisheng Zeng; Kunxian Shu
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

7.  Differential expression of small RNA pathway genes associated with the Biomphalaria glabrata/Schistosoma mansoni interaction.

Authors:  Fábio Ribeiro Queiroz; Luciana Maria Silva; Wander de Jesus Jeremias; Élio Hideo Babá; Roberta Lima Caldeira; Paulo Marcos Zech Coelho; Matheus de Souza Gomes
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

8.  MicroRNA-93 Regulates Hypoxia-Induced Autophagy by Targeting ULK1.

Authors:  Wen Li; Yue Yang; Zhaoyu Ba; Shupeng Li; Hao Chen; Xiaoyan Hou; Linlin Ma; Pengcheng He; Lei Jiang; Longxuan Li; Rongrong He; Liangqing Zhang; Du Feng
Journal:  Oxid Med Cell Longev       Date:  2017-10-03       Impact factor: 6.543

9.  Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.

Authors:  Jie-Yu Wang; Jia-Cheng Huang; Gang Chen; Dan-Ming Wei
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

10.  miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).

Authors:  Yan Qin; Xiao Chen; Zhihu Liu; Xiaopeng Tian; Zhibin Huo
Journal:  Med Sci Monit       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.